Drug Manufacturer Agrees To $1.89M Settlement To End Claims In Losartan MDL
CAMDEN, N.J. — A manufacturer of losartan products has agreed to pay $1,899,000 to settle claims brought against it by consumers and third-party payers (TPPs) who allege in a multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article